Grants and Contracts

 

PI Name of Award
Description of Study
Project
Start
Project
End
Awarded By Total Value
Muhammad Nabeel Patient Experience Research Study 6/3/2019 6/2/2020 Sparrow Foundation $10,000
Anthony Oliveri and Ken Rosenman Child Lead Exposure Elimination Innovation Grant – 2019 - A statewide program to prevent child take-home lead exposures in Michigan 6/1/2019 5/31/2020 MI Dept of Health & Human Services $133,536
Ramakrishna Mukkamala Co-I: Supratik Rayamajhi and Ralph Watson A Smartphone-Based Device for Cuff-Less and Calibration-Free Blood Pressure 5/16/2019 5/15/2023 National Inst of Health $750,000
Jatin Rana A Phase II Double-Blinded Placebo Controlled Randomized Trial of Salvage Radiotherapy with or without enhanced anti-androgen therapy with apalutamide 11/1/2018 10/31/2023 NRG-NIH Clinical Trial
Anthony Oliveri Supporting MI Agriculture 2019-Implementing Respiratory
Protection and Hazard Identification
10/1/2018 9/30/2019 State of MI $19,999
Jatin Rana Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therap for patients with stage III colon cancer and deficient DNA mismatch repair 10/1/2018 9/30/2023 NRG-NCI Clinical Trial
Borys Hrinczenko Randomized Double Blind Placebo Controlled Pilot Study of an Oral Selective Peripheral Opioid Receptor Antagonist in Advanced Nonsmall cell Lung Cancer  9/1/2018 8/31/2024 NRG-NCI Clinical Trial
Jatin Rana Phase 3 Newly Diagnosed Symptomatic Multiple Myeloma 8/1/2018 2/28/2019 NRG - NCI/NIH Clinical Trial
Jatin Rana Phase 3 Her 2 Negative Advance/Metastatic Breast Cancer 7/3/2018 7/21/2023 BIG Ten Cancer Consortium Clinical Trial
Ken Rosenman Evaluation of Silicosis, Asthma & COPD amount sand/gravel &
Stone Surface Miners
7/1/2018 12/31/2019 Alpha Foundation for the Improvement of
Mine Safety & Health Inc
$250,000
Ken Rosenman Worksite intervention to Mitigate Child Take Home Lead Exposure 6/1/2018 5/31/2019 MI Dept of Health & Human Services $75,000
Jatin Rana Phase 3 Evaluating the role of weight loss in adjuvant treatment of overweight/obese women with early breast cancer 6/1/2018 5/31/2023 NRG - NCI/NIH Clinical Trial
MSU Breslin Cancer Center Phase 3 Newly Diagnosed Acute Myeloid Leukemia unfit for standard chemotherapy 4/2/2018 4/30/2023 Helsinn HealthCare/MEI Pharma, INC Clinical Trial
Ralph Watson Epigenomics of Hypertension in Monozygotic Twins &
effect of salt intake
4/1/2018 3/31/2019 American Heart Assoc $109,658
Jatin Rana Phase 1/2 Advance AR + Triple Negative Breast Cancer 3/23/2018 3/31/2021 BIG Ten Cancer Consortium Clinical Trial
Jatin Rana Phase2 Metastatic or Advance Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma 11/20/2017 11/30/2021 BIG Ten Cancer Consortium Clinical Trial
Borys Hrinczenko Phase 2 Non-small Cell Lung Cancer 11/13/2017 11/30/2021 BIG Ten Cancer Consortium Clinical Trial
MSU Breslin Cancer Center Phase 3 Neoadjuvant Chemotherapy with Triple Negative Breast Cancer 11/1/2017 1/31/2023 NSABP Clinical Trial
Jatin Rana Phase 2 Unresponsive Non-Muscle Invasive Bladder Cancer 9/29/2017 9/28/2022 NRG - NCI/NIH Clinical Trial
Jatin Rana Phase 2 High Risk Myelodysplastic Syndrome 8/15/2017 7/31/2022 Helsinn HealthCare/MEI Pharma, INC Clinical Trial
Jatin Rana Phase 2/3 Replapsed or Refractory Multiple Myeloma 8/1/2017 7/31/2022 Millennium Pharmaceutical Clinical Trial
Jatin Rana The National Myelodysplastic Syndromes (MDS) Study 5/30/2017 2/28/2019 NRG - NCI/NIH Clinical Trial
Borys Hrinczenko Phase 2 Study of MM-121 in Combination with Docetaxel or Pemetrexed versus Docetasel or Pemetrexed Alone in Patients with Herebulin Positive Locally Advanced or Metastatic Non-small cell lung 5/1/2017 4/30/2021 Merrimack Pharmaceuticals Clinical Trial
Jatin Rana Phase 3 Triple Receptor Negative Breast Cancer with>1cm residual invasive cancer or positive lymph nodes 5/1/2017 12/31/2019 NRG - NCI SWOG Clinical Trial
Borys Hrinczenko Prospective, Lognitudinal Non-Interventional study for patients with low risk Myelofibrosis 2/2/2017 1/29/2022 Incyte Pharmaceutical Clinical Trial
MSU Breslin Cancer Center Phase 1/2 Relapsed or Refractory Diffuse Large B Cell Lymphoma 1/5/2017 1/5/2020 Incyte Pharmaceutical Clinical Trial
Melissa Millerick May Improved method for identifying Causative Antigen in
Hypersensitivity Pheumonitis
12/1/2016 11/30/2021 National Inst of Allergy & Infectious Diseases $978,194
MSU Breslin Cancer Center Molecular Analysis for Therapy Choice (MATCH) 10/3/2016 2/28/2019 NRG - NCI/NIH Clinical Trial
Jatin Rana Phase 2 Metastatic Hormone Receptor Positive Breast Cancer 9/8/2016 7/31/2021 BIG Ten Cancer Consortium Clinical Trial
Ken Rosenman Worker Compensation Surveillance 9/1/2016 8/31/2019 National Inst of Health $600,000
Borys Hrinczenko Phase 2 Esophageal Cancer 8/26/2016 7/31/2019 BIG Ten Cancer Consortium Clinical Trial
Borys Hrinczenko Phase 3 Stage 3 Colon Cancer 7/1/2016 6/30/2020 NRG - NCI/NIH Clinical Trial
Jatin Rana Phase 3 High Risk Hormone Receptor-Positive, HER2 Negative Breast Cancer 6/1/2016 2/28/2019 NRG - NIH SWOG Clinical Trial
Jatin Rana Phase 3 BRCA1/2, High Risk HER2 Negative Breast Cancer 6/1/2016 2/28/2019 NRG - NCI/NIH Clinical Trial
Borys Hrinczenko Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0011359C in subject 4/20/2016 12/31/2019 EMD Serono Inc Clinical Trial
Elahe Crockett-Torabi Research Education Program to increase diversity in health related research 4/1/2016 3/31/2021 National Inst of Health $798,243
Ken Rosenman Expanded Program in Occupational Injury & Illness Surveillance 7/1/2015 6/30/2020 Centers for Disease Control & Prevention $3,575,967
Melissa Millerick May A field based investigation of the generation of bioaerosol
containing Porcine Epidemic Diarrhea virus (PEDv) during
manure removals on swine farms in Michigan
4/16/2015 8/31/2019 Michigan Pork Producers Assoc $10,500
Borys Hrinczenko A phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metasta  2/26/2014 12/31/2019 EMD Serono Inc Clinical Trial
Ken Rosenman OEC Exposure Code Systems Update 10/1/2011 12/31/2018 Assoc of Occupational & Environmental Clinics $176,500